Consumer Alert: Zantac Users Be Aware
In September 2019, the FDA found low levels of NDMA (N-nitrosodimethylamine) in Zantac and its generic equivalent, ranitidine. The U.S. Environmental Protection Agency considers NDMA to be a substance capable of causing cancer.